http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201000440-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate | 2008-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201000440-A1 |
| titleOfInvention | METHOD OF TREATMENT OF CENTRAL NERVOUS SYSTEM AND DISORDERAL PAINS |
| abstract | A method for the therapeutic or prophylactic treatment of persons suffering from disorders of the peripheral or central nervous system, or conditions or at risk of developing such disorders and conditions, comprising the use of a pharmacologically effective amount of 3-phenylmethylaminomethylene pyrrolidine-2,4-dione (I) or a pharmaceutically acceptable salt, or prodrugs or solvate them. The use of (I) for the manufacture of a pharmaceutical composition for the treatment of such conditions or disorders is also disclosed. |
| priorityDate | 2007-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426062138 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135401618 |
Total number of triples: 18.